Plant Based API Market Size, Share, Trend Report 2026 to 2035
What is Plant Based API Market Size?
Global Plant Based API Market Size is valued at USD 33.05 Billion in 2025 and is predicted to reach USD 58.28 Billion by the year 2035 at a 6.2% CAGR during the forecast period for 2026 to 2035.
Plant Based API Market Size, Share & Trends Analysis Report By Type (Alkaloids, Anthocyanins, Flavonoids, Phenolic Acids, Terpenoids, Lignans and Stilbenes), By Application (Pharmaceuticals, Nutraceuticals, Herbal Based Industries), By Region, and Segment Forecasts, 2026 to 2035
Plant Based API Market Key Takeaways:
|
Active Pharmaceutical Ingredients (APIs) and excipients are the two most essential components in the manufacture of medication. The API is the chemical from which the medication is created. In contrast, the excipient is a component that isn't the drug but works as a medium that allows the body to absorb the medicine, including lactose or mineral oil, in a pill. The rising rate of chronic illnesses and the growing importance of generics are some of the vital drivers driving the growth of the Indian APIs industry.
Advances in active pharmaceutical ingredient (API) manufacture and the growth of the biotech sector are driving the market growth. The aging population positively impacts the development of several chronic and acute ailments that necessitate more advanced pharmaceuticals to mitigate their effects. This is why the global Active Pharmaceutical Ingredients (API) Market has been growing. COVID-19 has also had a major effect on the Active Pharmaceutical Ingredients (API) industry's growth.
Pharmaceutical companies have become the most significant industry in the globe during the pandemic due to the widespread use of various drugs to treat COVID-19 patients' symptoms and various medical conditions, including high fever, cough, and cold.
Recent Developments:
- In 2021-The University of Bristol identified a way for generating a major component of the malaria medicine artemisinin using genetically modified yeast. This procedure is more environmentally friendly and cost-effective than traditional medicine-making methods, which entail extracting it from the artemisia plant.
- In 2020-Amyris, a biotechnology company based in California stated that it had successfully manufactured a plant-based version of the anti-malarial medicine artemisinin. The medicine was created using a proprietary yeast strain and subsequently licensed to pharmaceutical companies for further development and commercialization.
Competitive Landscape:
Some Of The Plant Based API Market Players:
- Roquette Frères SA
- EVONIK Industries
- AG, Cargill, Inc
- Kothari Phytochemicals & Industries Ltd
- Medi pure Pharmaceuticals Inc.
- Centro flora Group
- Arborist, LLCs, BASF S
- Novartis AG
- Sanofi SA
- GlaxoSmithKline, plc,
- Hoffmann-La Roche AG
Market Segmentation:
The Plant-Based API market is segmented based on product and application. Based on the product, the Plant-Based API market is segmented as alkaloids, anthocyanins, flavonoids, phenolic acids, terpenoids, lignans, and stilbenes. By application, the market is segmented into pharmaceuticals, nutraceuticals, herbal-based industries, and others.
Based On Product, The Flavonoids Segment Is A Major Contributor In The Plant Based API Market
The flavonoids category will hold a major share of the global Plant Based API market in 2022. Because of its high amount of antioxidants and good anti-inflammatory properties, the flavonoid market has remained stable in recent years. It is one of the best on the market. Plant flavonoids have potential medicinal uses, which has led to their increased use in the pharmaceutical and nutraceutical businesses. Consumer demand for nutraceuticals is consequently driving the worldwide flavonoid market. Furthermore, the growing demand for convenience foods has expanded the usage of flavonoids in functional foods.
Herbal Based Industries Segment Witnessed Growth At A Rapid Rate
The herbal-based industries segment is projected to grow rapidly in the global Plant Based API market. Herbal treatments are used as alternative medicines in herbal therapy. They treat or prevent ailments, relieve symptoms, increase energy, relax, or lose weight. Herbs, unlike medicines, are not subjected to rigorous testing and regulation. Herbal medications are mostly used to treat chronic diseases and promote health. Still, their popularity is growing despite ineffective modern medicine for serious illnesses such as advanced cancer or new infectious diseases. This increased demand for herbal medication would broaden the worldwide market and open doors for other sellers to meet comparable demands. ,
The North America Plant Based API Market Holds A Significant Regional Revenue Share
The North America Plant Based API market is expected to register the highest market share in revenue soon. Substantial market participants, significant healthcare spending, and early product availability influence the market in North America. Furthermore, the U.S.'s vast patient population and rising supply of active pharmaceutical ingredients (API) fuel the industry there. The U.S. administration supports the creation of plant-based APIs by sponsoring and awarding research grants. In a similar vein, Canada is funding the creation of plant-based APIs. The nation is concentrating on creating new technologies to extract plant-based APIs effectively. The Canadian government is awarding funds to scientists and beginning to encourage the development of the market for plant-based APIs.
In addition, Asia Pacific is projected to grow at a rapid rate. One of the top nations for the manufacture of herbal medicines is China. Currently, China is concentrating on creating plant-based APIs for the pharmaceutical sector. The market in the region is boosted by favorable government initiatives, changing lifestyles that lead to the emergence of diseases, an increase in R&d expenditures, and technological innovations in drug production processes.
Plant Based API Market Report Scope :
| Report Attribute | Specifications |
| Market Size Value In 2025 | USD 33.05 Billion |
| Revenue Forecast In 2035 | USD 58.28 Billion |
| Growth rate CAGR | CAGR of 6.2% from 2026 to 2035 |
| Quantitative units | Representation of revenue in US$ Billion, and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report coverage | The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
| Segments covered | Type And Application |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | Roquette Frères SA, EVONIK Industries, AG, Cargill, Inc., Kothari Phytochemicals & Industries Ltd, Medipure Pharmaceuticals Inc., Centroflora Group, Arboris, LLCs, BASF SE, Novartis AG, Sanofi SA, GlaxoSmithKline, plc, F. Hoffmann-La Roche AG |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Plant Based API Market :
Plant Based API Market, By Type-
- Alkaloids
- Anthocyanins
- Flavonoids
- Phenolic Acids
- Terpenoids
- Lignans and Stilbenes
- Others
Plant Based API Market, By Application-
- Pharmaceuticals
- Nutraceuticals
- Herbal Based Industries
- Others
Plant Based API Market, By Region-
- North America-
- The US
- Canada
- Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
- Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Plant Based API Market Size is valued at USD 33.05 Billion in 2025 and is predicted to reach USD 58.28 Billion by the year 2035
Plant Based API Market expected to grow at a 76.2% CAGR during the forecast period for 2026 to 2035
Roquette Frères SA, EVONIK Industries, AG, Cargill, Inc., Kothari Phytochemicals & Industries Ltd, Medipure Pharmaceuticals Inc., Centroflora Group, Arboris, LLCs, BASF SE, Novartis AG, Sanofi SA, GlaxoSmithKline, plc, F. Hoffmann-La Roche AG and Others.
Type And Application are the key segments of the Plant Based API Market.
North America region is leading the Plant Based API Market.